Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2025-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Botriomycomas are frequent benign tumors in children. Their appearance on the central catheter orifice is a known event in clinical practice, but one that has been little studied. This lesion could lead to changes in pathways and an increase in the number of sepsis events, which would promote thrombosis and thus depletion of venous capital in patients who have been dependent on a central line for many years.

This study is a pilot study which will enable us to better identify the risk factors for the development of such a tumour, and to take stock of the different treatments used and their respective efficacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Home Parenteral Nutrition Intestinal Failure Central Line Botriomycoma Infection Sepsis Antibiotics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case / patients

Pediatric patients requiring a long-term central line for home parenteral nutrition:

* home parenteral nutrition patients
* diagnosed with at least on episode of botriomycoma on their central line
* 0 to 18 years of age at diagnosis of botriomycoma

No interventions assigned to this group

Control

Pediatric patients requiring a long-term central line for home parenteral nutrition:

* home parenteral nutrition patients
* never diagnosed with an episode of botriomycoma on their central line
* 0 to 18 years of age at diagnosis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* home parenteral nutrition patients
* never diagnosed with an episode of botriomycoma on their central line
* 0 to 18 years of age at diagnosis

Exclusion Criteria

* Botriomycoma more than 10 years old at time of data collection (or lack of data)
* Patient over 18 years of age
* Not on home parenteral nutrition patients

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Mère-Enfant

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL23_0638

Identifier Type: -

Identifier Source: org_study_id